Viracor Eurofins, a health innovation company located in Lee’s Summit, Missouri, has developed an at-home COVID-19 test kit that has been approved by the U.S. Food and Drug Administration. The company also released a COVID-19 saliva test on Monday for health care providers to administer, and it hopes to release an at-home version in the next few months.
“It’s really part of our mission to be a part of the solution and the continuing fight of this pandemic because we know that it really is going to be a collective response that is going to give us success against the virus,” said Dr. Michelle Altrich, President of Viracor Eurofins. “We’re proud to be playing a leading role.”
Viracor’s nasal test is less invasive than others on the market, and the swab is similar to a Q-tip. Users need only to stick the swab a couple of centimeters to an inch inside their nose.
“It isn’t the brain tickler type of swab that people have heard about or are familiar with from past flu tests or previous tests for the coronavirus,” said Dr. Altrich.
The announcement comes just two months after Viracor Eurofins announced it had developed a new testing method that reduces the price per person for a COVID-19 test and delivers results within 48 hours.
From Missouri being highlighted by Vice President Mike Pence after launching its partnership with Google to help health care providers connect with Missouri manufacturers and suppliers of personal protective equipment; to Washington University School of Medicine in St. Louis beginning COVID-19 vaccine trials; to Kansas City being chosen as the testing ground for an experimental coronavirus vaccine; Missouri is continuing to lead the way in the fight against COVID-19.